Surrozen (SRZN) - Price-to-Projected Revenue Ratio

surrozen.com (SRZN) - corporate logo

The expected P/S ratio confirms market optimism regarding the prospects of Surrozen, Inc. (SRZN). High authority in creating antibodies for regeneration and the development of organ restoration methods without transplantation ensure brand resilience. The innovative Wnt-pathway platform strengthens investor confidence, while 36.00 serves as the current metric value, capturing the real-time market valuation of the company's potential.

SRZN (surrozen.com) Future Price to Revenue history from 04/02/2023 to 11/14/2026

Surrozen Inc. - analytical breakdowns and key metrics (SRZN)

- market price and analyst price targets:
Price Chart Surrozen|SRZN - Fair Value Consensus
- market capitalization indicators:
Market Value Surrozen Inc.|SRZN - Total Enterprise Value
- book value of equity indicators:
Accounting Value per Share Surrozen|SRZN - Net Asset Value|Market Capitalization to Book Value Ratio surrozen.com|SRZN - Company Assets
- debt and liquidity data:
Debt to Equity Surrozen, Inc.|SRZN - Long-Term Debt to Capital Ratio|Short-Term Debt to Equity Ratio Surrozen, Inc.|SRZN - Aggregate Debt Obligations|Debts to Book Capitalization Surrozen Inc.|SRZN - Long-Term Debt Volume|Company Short-Term Debt Surrozen|Quick Ratio surrozen.com
- net income and valuation multiples indicators:
SRZN - Net Income|Future Profit Surrozen, Inc.|SRZN - Business Payback Period|Future Price to Earnings Surrozen Corp|SRZN - Growth-Adjusted Market Cap to Net Income|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Surrozen Inc.|SRZN - Income before deduction of interest, taxes and amortization|Net earnings per share for the last 12 months Surrozen|SRZN - Earnings per one share for the last 12 months|Year-over-year earnings per share growth for the last twelve months surrozen.com|SRZN - Earnings per share growth this year|Net earnings per share growth forecast for next year Surrozen, Inc.
- sales volume and revenue information:
SRZN - Company Gross Revenue|Company Future Sales Volume Surrozen|SRZN - Market Cap to Sales Volume|Forward P/S Multiple Surrozen Inc.
Summary company analysis:Surrozen SRZN
Original product of surrozen.com

This indicator measures the market value of the business relative to projected annual sales, reflecting the extent to which investor expectations for future cash flows are priced in. By analyzing the projected price-to-sales ratio, one can assess the speculative premium attached to the valuation of Surrozen, Inc. (SRZN), whose current revenues depend on funding for research and development in tissue regeneration.

Analysis of competing companies

Price-to-Projected Revenue Ratio Mesoblast MESO|Forward Price to Sales LCTX|CCEL - Price-to-Projected Revenue Ratio|Market Cap to Future Revenue Ratio FibroBiologics, Inc.|LGVN (Longeveron Inc.) - Forward Price-to-Revenue Multiple|Future Price to Revenue BRTX (BioRestorative Therapies, Inc.)|CELZ (Creative Medical Technology Holdings, Inc.) - Forward P/S Multiple